About ConduITS

The Icahn School of Medicine at Mount Sinai Clinical and Translational Science Award (CTSA) was renewed for a second five-year term in 2015 with a $34 million grant. The CTSA Program of the National Center for Advancing Translational Sciences (NCATS) mission is to accelerate discoveries, development, and delivery of new treatments to improve health outcomes across the lifespan.

The award supports the ISMMS Institutes for Translational Sciences’ strategic plan to develop an infrastructure to support research and educate the next generation of investigators. ISMMS is one of 60 CTSA-funded hubs across the country. CTSA hubs are expected to streamline the research process to get studies up and running faster; to enhance collaborations with other hubs, community providers, patients, and industry; and to promote team science and develop effective methods for recruitment and retention of clinical research participants. ConduITS accomplishes this by:

  • Providing consultation, oversight, and facilities for clinical and translational research
  • Engaging the community and its affiliates to translate health benefits to the public
  • Developing new methodologies to improve trial design and reduce participant burden


ConduITS will advance human health by transforming this hub into a translational research laboratory, partnering with our diverse patient population, other stakeholders, institutional clinicians and scientists, and investigators at other CTSA Network Hubs to ensure high quality research, research education, and development of unique, innovative resources to catalyze translation of biomedical discoveries across the lifespan.

We will accomplish this by achieving the following Specific Aims:

  1. Ensure that translational researchers have the skills and knowledge necessary to advance translation of discoveries by developing innovative curricula for high quality clinical and translational research training of students, investigators and research staff at all levels.
  2. Expand programs to further promote workforce diversity through recruitment, education, mentoring and retention of the most talented students, faculty and researchers,
  3. Foster a collaborative, collegial, transdisciplinary (shared) environment within our CTSA hub and the CTSA Network that includes incentives for formation of multi-disciplinary translational teams. We will also collaborate with other CTSA hubs to improve translational research.
  4. Coordinate the health care delivery and translational research enterprise by integrating secure electronic health records (EHRs), web-based clinical trials management systems and institutional databanks to better engage patients and community clinicians in clinical trials and community engaged research.
  5. Engage a diverse group of stakeholders at the local and national level in all phases of translational research, including patients, caregivers, clinicians, and healthcare delivery representatives, advocacy groups, NIH Institutes & Centers, other NCATS funded CTSA Hubs, biotech and pharmaceutical companies, and venture capital firms.
  6. Incorporate translational research across the lifespan with particular focus on pediatric research, geriatric populations, and special populations affected by health disparities.
  7. Continue to innovate and streamline research administrative oversight and processes to minimize roadblocks, identify and rectify gaps, ensure quality and assurance, monitor outcomes and garner feedback from stakeholders.